Exelixis
EXEL
#1694
Rank
NZ$20.67 B
Marketcap
NZ$76.79
Share price
-0.02%
Change (1 day)
25.33%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company